The overall aim of the project is to establish an international multi-cohort research platform of HIV/HBV-coinfected individuals treated with tenofovir to improve our understanding of the determinants of treatment outcomes.
Age range
16 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
HBV suppression
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint
HBsAg loss
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint
HBeAg loss
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint
Transaminase normalization
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint
Liver fibrosis change
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint
Treatment interruption or change
Timeframe: 2 years of TDF/TAF-containing treatment and last available timepoint